Ascidian Therapeutics
Ting-Wen Cheng has a diverse work experience in the field of scientific research. They are currently working as a Research Fellow at Ascidian Therapeutics since 2023. Prior to this, they held various roles at Pfizer, starting as a Senior Scientist in October 2015 and progressing to become a Principal Scientist in April 2019. They then served as a Senior Principal Scientist from October 2021 until June 2023. Before joining Pfizer, Ting-Wen Cheng worked as a Postdoctoral Fellow, first at the University of California, Davis from 2009 to 2011, and then at Pfizer from 2011 to 2015.
Ting-Wen Cheng obtained a Doctor of Philosophy (Ph.D.) degree in Cell and Developmental Biology from the University of California, Davis.